Celldex Therapeutics buy Morgan Stanley
Start price
22.07.26
/
50%
€30.47
Target price
22.07.27
€35.07
Performance (%)
9.48%
Price
31.07.26
€32.95
Summary
This prediction is currently active. The BUY prediction by Morgan_Stanley shows slight gains of 9.48%. This prediction currently runs until 22.07.27. The prediction end date can be changed by Morgan_Stanley at any time. Morgan_Stanley has 50% into this predictionPerformance without dividends (%)
| Name | 1w |
|---|---|
| Celldex Therapeutics | 7.399% |
| iShares Core DAX® | 2.591% |
| iShares Nasdaq 100 | -0.915% |
| iShares Nikkei 225® | 0.145% |
| iShares S&P 500 | -0.367% |
Comments by Morgan_Stanley for this prediction
In the thread Celldex Therapeutics diskutieren
Celldex Therapeutics (CLDX) had its price target lowered by Morgan Stanley from $44.00 to $40.00. They now have an "overweight" rating on the stock.
Ratings data for CLDX provided by MarketBeat
Stopped prediction by Morgan_Stanley for Celldex Therapeutics
Celldex Therapeutics
Start price
Target price
Perf. (%)
€16.30
09.05.25
09.05.25
€38.34
09.05.26
09.05.26
74.29%
10.05.26
10.05.26
Celldex Therapeutics
Start price
Target price
Perf. (%)
€18.40
20.03.25
20.03.25
€42.18
20.03.26
20.03.26
42.39%
21.03.26
21.03.26